54.64 USD
↗ 0.54 (1.00%)AT CLOSE (11:59 AM EDT)
BioMarin Pharmaceuticals Inc
BMRNNASDAQ • USD
53.90
↘ 0.74 (1.35%)
POST MARKET (AS OF 06:18 PM EDT)
Post Market
AS OF 06:18 PM EDT
53.90
↘ 0.74 (1.35%)
Market: CLOSED
Open?$54.51
High?$54.97
Low?$54.08
Prev. Close?$54.10
Volume?2.1M
Avg. Volume?1.9M
VWAP?$54.55
Rel. Volume?1.11x
Bid / Ask
Bid?$51.77 × 100
Ask?$57.78 × 100
Spread?$6.01
Midpoint?$54.78
Valuation & Ratios
Market Cap?10.5B
Shares Out?192.3M
Float?190.4M
Float %?99.1%
P/E Ratio?30.12
P/B Ratio?1.73
EPS?$1.81
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?5.21Strong
Quick Ratio?3.50Strong
Cash Ratio?1.73Strong
Debt/Equity?0.10Low
ValuationFAIRLY VALUED
Score67/100
P/E?30.1PRICEY▾
P/B?1.73CHEAP▾
P/S?3.26FAIR▾
P/FCF?14.5CHEAP▾
EV/EBITDA?20.0HIGH▾
EV/Sales?3.04FAIR▾
Returns & Efficiency
ROE?5.7%FAIR▾
ROA?4.6%FAIR▾
Cash Flow & Enterprise
FCF?$725.0M
Enterprise Value?$9.8B
News
Profile
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Employees
3.2K
Market Cap
10.5B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1999-07-23
Address
105 DIGITAL DRIVE
NOVATO, CA 94949
Phone: (415) 506-6700
NOVATO, CA 94949
Phone: (415) 506-6700